Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2023 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 1901

Showing 1-25 of 1901 citing articles:

Alzheimer's disease drug development pipeline: 2024
Jeffrey L. Cummings, Yadi Zhou, Garam Lee, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 2
Open Access | Times Cited: 91
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 90
The Burden of Chronic Disease
Karen Hacker
Mayo Clinic Proceedings Innovations Quality & Outcomes (2024) Vol. 8, Iss. 1, pp. 112-119
Open Access | Times Cited: 77
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 63
Mitochondrial dysfunction in neurodegenerative disorders
Madelyn Klemmensen, Seth H. Borrowman, Colin Pearce, et al.
Neurotherapeutics (2023) Vol. 21, Iss. 1, pp. e00292-e00292
Open Access | Times Cited: 62
Revolutionizing the Early Detection of Alzheimer’s Disease through Non-Invasive Biomarkers: The Role of Artificial Intelligence and Deep Learning
Aristidis G. Vrahatis, Konstantina Skolariki, Marios G. Krokidis, et al.
Sensors (2023) Vol. 23, Iss. 9, pp. 4184-4184
Open Access | Times Cited: 60
Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease
Suzanne E. Schindler, Douglas Galasko, Ana C. Pereira, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 7, pp. 426-439
Open Access | Times Cited: 58
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 51
Polyamines: their significance for maintaining health and contributing to diseases
Mengjuan Xuan, Xinyu Gu, Juan Li, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive Impairment
Manuel Montero‐Odasso, Guangyong Zou, Mark Speechley, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2324465-e2324465
Open Access | Times Cited: 45
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Giovanni B. Frisoni, Cristina Festari, Federico Massa, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 302-312
Open Access | Times Cited: 44
An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease
Yashumati Ratan, Aishwarya Rajput, Sushmita Maleysm, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1398-1398
Open Access | Times Cited: 43
Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer’s Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study
Yu-Chieh Hsu, Yen-Yu Huang, Shin‐Yu Tsai, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 16-16
Open Access | Times Cited: 41
Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 32
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
Paras Mani Giri, Anurag Banerjee, Arpita Ghosal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3995-3995
Open Access | Times Cited: 26
The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis
André F. Batista, Khyrul Khan, Maria-Tzousi Papavergi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 817-817
Open Access | Times Cited: 22
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Curcumin Mitigates the High-Fat High-Sugar Diet-Induced Impairment of Spatial Memory, Hepatic Metabolism, and the Alteration of the Gut Microbiome in Alzheimer’s Disease-Induced (3xTg-AD) Mice
Gopal Lamichhane, Jing Liu, Su‐Jeong Lee, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 240-240
Open Access | Times Cited: 20
Alzheimer's disease pathophysiology in the Retina
Bhakta Prasad Gaire, Yosef Koronyo, Dieu‐Trang Fuchs, et al.
Progress in Retinal and Eye Research (2024) Vol. 101, pp. 101273-101273
Open Access | Times Cited: 20
Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease
Hai V. Nguyen, Shweta Mital, David S. Knopman, et al.
Neurology (2024) Vol. 102, Iss. 7
Closed Access | Times Cited: 19
Impact of nanoplastics on Alzheimer ’s disease: Enhanced amyloid-β peptide aggregation and augmented neurotoxicity
Xiaoli Gou, Yongchun Fu, Juan Li, et al.
Journal of Hazardous Materials (2024) Vol. 465, pp. 133518-133518
Closed Access | Times Cited: 17
Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease
Feixiong Cheng, Fei Wang, Jian Tang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101379-101379
Open Access | Times Cited: 17
The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 17
Disentangling tau: One protein, many therapeutic approaches
Courtney Lane‐Donovan, Adam L. Boxer
Neurotherapeutics (2024) Vol. 21, Iss. 2, pp. e00321-e00321
Open Access | Times Cited: 16
Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
Xuemei Zeng, Yijun Chen, Anuradha Sehrawat, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top